newsfilter
← Latest News
Business Wire·

Inogen Announces Second Quarter 2026 Financial Results

Reported second quarter revenue of $95.1 million Company raises full-year adjusted EBITDA guidance to approximately $4.0 million Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative